Comparison of Nebulized Versus Intravenous Milrinone on Reducing Pulmonary Arterial Pressure in Patients with Pulmonary Hypertension Candidate for Open-cardiac Surgery: A Double-Blind Randomized Clinical Trial

CONCLUSIONS: Nebulized milrinone administration before weaning off cardiopulmonary bypass (CPB) can be accelerated and facilitate weaning off CPB. Moreover, despite maintaining MAP, nebulized milrinone significantly reduces mPAP. According to the results of this study, nebulized milrinone is recommended in patients undergoing cardiac surgery with pulmonary hypertension.PMID:36818483 | PMC:PMC9923341 | DOI:10.5812/aapm-122994

Source: Atherosclerosis - February 23, 2023 Category: Cardiology Authors: Sara Jorairahmadi Fatemeh Javaherforooshzadeh Marziyeh Babazadeh Behnam Gholizadeh Nima Bakhtiari Source Type: research